Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Wednesday 12 June, 2013

AstraZeneca PLC

Director/PDMR Shareholding

RNS Number : 8940G
AstraZeneca PLC
12 June 2013
 



Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC ordinary shares, has changed as detailed below. 

 

On 11 June 2013, Mr Lowth was granted awards under the terms of the AstraZeneca Investment Plan (AZIP) and the AstraZeneca Performance Share Plan (AZPSP) over the Company's ordinary shares.  A summary of these plans can be found in the AstraZeneca Annual Report and Form 20-F Information 2012 which is available on the Company's website www.astrazeneca.com.

 

 

 

Name

Shares awarded under AZIP

Shares awarded under AZPSP

Award price per share

 

Simon Lowth

 

11,305

 

67,834

 

3297p

 

 

The AZIP award is subject to a four-year performance period (1 January 2013 to 31 December 2016) and a subsequent four-year holding period (1 January 2017 to 31 December 2020).

 

The AZPSP award is subject to a three-year performance period (1 January 2013 to 31 December 2015).

 

More information about the performance measures that relate to these AZIP and AZPSP awards is set out in the Remuneration Committee Chairman's Speech and Presentation which was presented to shareholders at the Company's 2013 AGM, and which can be found at www.astrazeneca.com/Investors/Shareholder-information/Annual-General-Meeting.

 

As a result of these awards, Mr Lowth has an interest in 340,016 ordinary shares which represents approximately 0.03% of the Company's issued ordinary capital.

 

A C N Kemp

Company Secretary

12 June 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUROROSANAAR

a d v e r t i s e m e n t